- Home
- CWAN vs ELAN Comparison
CWAN vs ELAN Comparison
Compare CWAN & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWAN
- ELAN
- Stock Information
- Founded
- CWAN 2004
- ELAN 1954
- Country
- CWAN United States
- ELAN United States
- Employees
- CWAN N/A
- ELAN N/A
- Industry
- CWAN Computer Software: Prepackaged Software
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- CWAN Technology
- ELAN Health Care
- Exchange
- CWAN Nasdaq
- ELAN Nasdaq
- Market Cap
- CWAN 5.8B
- ELAN 7.2B
- IPO Year
- CWAN 2021
- ELAN 2018
- Fundamental
- Price
- CWAN $20.84
- ELAN $14.13
- Analyst Decision
- CWAN Buy
- ELAN Buy
- Analyst Count
- CWAN 10
- ELAN 7
- Target Price
- CWAN $31.50
- ELAN $16.17
- AVG Volume (30 Days)
- CWAN 3.5M
- ELAN 4.1M
- Earning Date
- CWAN 08-06-2025
- ELAN 08-07-2025
- Dividend Yield
- CWAN N/A
- ELAN N/A
- EPS Growth
- CWAN N/A
- ELAN N/A
- EPS
- CWAN 1.71
- ELAN 0.75
- Revenue
- CWAN $475,948,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- CWAN $63.46
- ELAN $4.33
- Revenue Next Year
- CWAN $29.41
- ELAN $4.75
- P/E Ratio
- CWAN $12.12
- ELAN $19.20
- Revenue Growth
- CWAN 23.21
- ELAN 1.42
- 52 Week Low
- CWAN $19.46
- ELAN $8.02
- 52 Week High
- CWAN $35.71
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- CWAN 36.76
- ELAN 44.72
- Support Level
- CWAN $21.00
- ELAN $14.61
- Resistance Level
- CWAN $21.66
- ELAN $15.00
- Average True Range (ATR)
- CWAN 0.63
- ELAN 0.35
- MACD
- CWAN -0.04
- ELAN -0.13
- Stochastic Oscillator
- CWAN 7.76
- ELAN 5.80
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.